Abbott rakes in earnings despite infant formula investigation but Nutrition suffers sales loss
date:Jul 22, 2022
that the company has leading positions in attractive long-term growth markets. Our business remains very strong, he says.

Tainted growth?
Delving into details of its Nutrition sales, the company outlines that excluding sales associated with product recalls in the current and prior years, sales in the segment increased 3.8% on an organic basis in Q2.

The companys product recall caused bottlenecks across the already strained supply chain in the US. Amid nationwide shortages and consumers scra
6/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/20 10:02